全文预览

老年肺结核患者抗结核药物性肝损害的预防探讨

上传者:塑料瓶子 |  格式:doc  |  页数:4 |  大小:0KB

文档介绍
量的措施,有望使患者平安渡过化疗强化期期,使抗结核化疗顺利完成。但上述措施是否会导致化疗疗程延长、远期复发率增高尚需进一步观察。Р 参考文献: Р [1]Fernandez VA,Sopefia B,Fernandez VJ,et al.The influence of risk factors on the severity of antituberculosis drug-induced hepatotoxicity[J].Tuberc Lung Dis,2004,8(12):1499-1505. Р [2]Yew WW,.antituberculosis drugs and hepatotoxicity[J]. Respirology, 2006,11(6):699-707. Р [3]Tostmann A,Boeree MJ,Aarnoutse RE,et al.Antituberculosis drug-induced hepatotoxicity:concise up-to-date review[J].J Gastroenterol Hepatol,2008,23(2):192-202. Р [4]Benichou C,Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11(2):272-176. Р [5]Frieden TR,Sterling TR,Munsiff SS,et al.Tuberculosis[J].Lancet,2003,362(9387):887-899. Р [6]郭英江,崔得健.抗结核病所致肝损害[J].中华结核和呼吸杂志,1998,21(5):308-309. Р 编辑/王海静

收藏

分享

举报
下载此文档